管状脑肿瘤活检提高皮层下病变的诊断率
该研究对比了2010至2018年间18例开放经管状活检与146例立体定向针吸活检,管状活检提供的组织体积更大(1.26 cm³ 对 0.3 cm³,P<0.0001),非诊断性样本率在立体定向组为13%、经管状组为0%,立体定向组有6例因诊断需要再次手术,而经管状组无患者因获取诊断标本需再次手术。作者结论认为经管状活检是针吸活检的可行替代方案,诊断成功率高且并发症可接受。
要点
- 管状活检组织体积1.26 cm³,显著大于针吸活检的0.3 cm³(P<0.0001)。
- 非诊断性样本率立体定向组13% vs 经管状组0%(P=0.13)。
- 立体定向组6例因诊断需再次手术,经管状组无患者因诊断需再次手术。
核心结论
- 作者认为立体定向经管状活检是立体定向针吸活检的可行替代方案,诊断成功率高且并发症可接受。
- 随着分子数据日益驱动治疗决策,可能需要能提供大组织体积的额外活检技术以适应病理学家和治疗肿瘤学家的新需求。
研究设计与样本
- 对比研究,纳入2010至2018年间18例接受开放经管状活检的患者与146例接受立体定向活检的患者。
主要发现
- 经管状活检提供给病理学家的组织体积大于针吸活检(1.26 cm³ 对 0.3 cm³;P<0.0001)。
- 立体定向活检的非诊断性样本率高于经管状活检(13% 对 0%;P=0.13)。
- 6例接受立体定向活检的患者因诊断需要再次手术,而经管状活检患者无因获取诊断标本需再次手术。
- 术后血肿是两组中最常见的术后并发症。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Molecular data has become an essential part of the updated World Health Organization (WHO) grading of central nervous system tumors. However, stereotactic needle biopsies provide only small volume specimens and limit the extent of histologic and molecular testing that can be performed. We assessed the use of a tubular retractor-based minimally invasive biopsy technique to provide improved tissue yield and diagnostic data compared to needle biopsy. METHODS: Eighteen patients underwent an open transtubular biopsy compared to 146 stereotactic biopsies during the years of 2010-2018. RESULTS: Tubular biopsies resulted in a higher volume of tissue provided to the pathologist than needle biopsies (1.26 cm3 vs. 0.3 cm3; p < 0.0001). There was a higher rate of non-diagnostic sample with stereotactic compared to transtubular biopsy (13% vs. 0%; p = 0.13). Six patients who underwent stereotactic biopsy required reoperation for diagnosis, while no transtubular biopsy patient required reoperation in order to obtain a diagnostic specimen. Postoperative hematoma was the most common post-operative complication in both groups. CONCLUSIONS: Stereotactic transtubular biopsies are a viable alternative to stereotactic needle biopsies with excellent rates of diagnostic success and acceptable morbidity relative to the needle biopsy technique. As molecular data begins to increasingly drive treatment decisions, additional biopsy techniques that afford large tissue volumes may be necessary to adapt to the new needs of pathologists and treating oncologists.
引用
- Bander ED, Jones SH, Pisapia D, et al. Tubular brain tumor biopsy improves diagnostic yield for subcortical lesions. J Neurooncol. 2018. PMID: 30446900. doi:10.1007/s11060-018-03014-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。